5LINX Launches CBDecember

Rochester, NY, December 12, 2018 --(PR.com)-- In celebration of its popular OXZGEN line of CBD
products, 5LINX is rolling out a month-long campaign around the theme of “CBDecember.”

CBD, which is short for Cannabidiol, is derived from the cannabis plant, but does not contain THC. For
this reason, it is highly popular for its effectiveness in reducing pain, treating ailments, and managing
symptoms without the psychoactive properties of THC. It is so popular, in fact, that experts from The
Brightfield Group have recently estimated that CBD products could represent a $22 billion industry by
2022.

The CBDecember campaign will include numerous elements throughout the month, including ongoing
flash sales on various OXZGEN CBD products. The campaign will also feature stories of some of the
thousands of people who have experienced tremendous benefits from the OXZGEN line. In addition,
5LINX is offering a special OXZGEN product bundle that allows anyone to become a distributor and
waives the normal enrollment fee.

Juwan Howard, retired NBA champion and current assistant coach with the Miami Heat, is a vocal
advocate for the healing and therapeutic benefits of CBD. “I believe OXZGEN is the finest CBD product
in the market,” he stated. “It has helped me tremendously, and I know it can help thousands of others.”

5LINX is a direct sales company headquartered in Rochester, NY with 35 local employees and several
thousand independent sales representatives nationwide. The company markets a wide range of products
and services in the home, business, and wellness categories. This includes their MontaVida line of coffee
and tea, as well as their OXZGEN line of CBD products. For more information, visit 5LINX.com

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
5LINX
Michael Gilbert
585-370-5919
Contact via Email
5LINX.com

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/772078

Page 2/2
PR.com Press Release Distribution Terms of Use